DCGI bans online medicine sale; tasks FICCI to frame guidelines

DCGI bans online medicine sale; tasks FICCI to frame guidelines

According to a report cited by a news daily, the Drugs Controller General of India (DCGI) has placed a ban on selling medicines online.

It has asked all the drug control administrations of state governments and union territories to take action against the epharmacies selling medicines, because of pending submission of the expert committee report by Dr Harshadeep Kamble (Commissioner, food and drugs administration, Maharashtra) to the Centre.

DCGI had appointed industry body FICCI as the nodal agency to consolidate and frame guidelines for online sales of medicines through ecommerce channels in June 2015.

It may be recalled that All India Organisation of Chemists & Druggists (AIOCD) went for a day’s strike in October 2015 against the central government’s move to regularise sale of medicines through the internet. It reasoned that it would lead to the sale of illegal and spurious drugs along with increasing unemployment.

The fear is not underestimated as it may be recalled that in May 2015, ecommerce marketplaces Snapdeal and Shopclues were spotted selling termination of pregnancy (MTP) pills and Sildenafil Citrate (Viagra) tablets, which only urologists, psychiatrists, endocrinologists and dermatologists could prescribe.

Earlier in December, the Drugs Consultative Committee, the advisory arm of the DCGI, had constituted a seven-member subcommittee to examine the issue of sale of drugs on the Internet, to understand the risks and concerns of pharmaceutical’s online sales.

Online pharmacies in India have significantly increased due to growing ecommerce in India. There are various online medicine retailers who are selling medicines following different models. Online medical store Merapharmacy.com sells generic medicines at discounted rates whereas companies like Netmeds.com and Medidart.com supplies prescription-based medicines. Medstar is one epharmacy that states that it does not deliver Schedule H and H1 Drugs without prescription from a registered medical practitioner.


Welcome to Flash Feed, your essential source for breaking news and innovation from around the web – bite-sized and updated all day.


You have reached your limit of free stories
Become An Inc42 Plus Member

Become a Startup Insider in 2024 with Inc42 Plus. Join our exclusive community of 10,000+ founders, investors & operators and stay ahead in India’s startup & business economy.

2 YEAR PLAN
₹19999
₹7999
₹333/Month
Unlock 60% OFF
Cancel Anytime
1 YEAR PLAN
₹9999
₹4999
₹416/Month
Unlock 50% OFF
Cancel Anytime
Already A Member?
Discover Startups & Business Models

Unleash your potential by exploring unlimited articles, trackers, and playbooks. Identify the hottest startup deals, supercharge your innovation projects, and stay updated with expert curation.

DCGI bans online medicine sale; tasks FICCI to frame guidelines-Inc42 Media
How-To’s on Starting & Scaling Up

Empower yourself with comprehensive playbooks, expert analysis, and invaluable insights. Learn to validate ideas, acquire customers, secure funding, and navigate the journey to startup success.

DCGI bans online medicine sale; tasks FICCI to frame guidelines-Inc42 Media
Identify Trends & New Markets

Access 75+ in-depth reports on frontier industries. Gain exclusive market intelligence, understand market landscapes, and decode emerging trends to make informed decisions.

DCGI bans online medicine sale; tasks FICCI to frame guidelines-Inc42 Media
Track & Decode the Investment Landscape

Stay ahead with startup and funding trackers. Analyse investment strategies, profile successful investors, and keep track of upcoming funds, accelerators, and more.

DCGI bans online medicine sale; tasks FICCI to frame guidelines-Inc42 Media
DCGI bans online medicine sale; tasks FICCI to frame guidelines-Inc42 Media
You’re in Good company